It is now commonly understood that breast cancer is not one form of cancer, but many different "subtypes" of cancer.  These subtypes of breast cancer are generally diagnosed based upon the presence, or lack of, three "receptors" known to fuel most breast cancers: estrogen receptors, progesterone receptors and human epidermal growth factor receptor 2 (HER2). The most successful treatments for breast cancer target these receptors.
Unfortunately, none of these receptors are found in women with<unk> . A<unk>  diagnosis means that the offending tumor is estrogen receptor-negative, progesterone receptor-negative and HER2-negative, thus giving rise to the name<unk> ." On a positive note, this type of breast cancer is typically responsive to chemotherapy. Because of its<unk><unk>  status, however,<unk><unk>  tumors generally do not respond to receptor targeted treatments. Depending on the stage of its diagnosis,<unk>  can be particularly aggressive, and more likely to recur than other subtypes of breast cancer.<unk>  accounts for approximately 15% of all breast cancer cases. It occurs most often in African American and younger women.  Because it is a recently recognized form of breast cancer, there is very little known about its pathology. Thus, there is an urgent need for targeted research and better treatment options for this disease.
Triple Negative Breast Cancer
Breast cancer legacy
Inflammatory breast cancer
Papillary carcinoma of the breast
Paget's disease of the breast
Rhabdomyosarcoma staging
Liposarcoma staging
Carcinoma in situ